| Category: Equity: Sectoral-Pharma and Healthcare |
| Launch Date: 28-12-2015 |
| Asset Class: Equity |
| Benchmark: NIFTY Pharma TRI |
| Expense Ratio: 2.14% As on (30-11-2024) |
| Status: Open Ended Schemes |
| Minimum Investment: 5000.0 |
| Minimum Topup: 1000.0 |
| Total Assets: 1,213.86 Cr As on (29-11-2024) |
| Turn over: 22.57 |
| 1-Year Ret (%) | 3-Yrs Ret (%) | 5-Yrs Ret (%) | 10-Yrs Ret (%) | Since Launch Ret (%) | |
|---|---|---|---|---|---|
| Tata India Pharma & Healthcare Fund-Regular Plan-Growth | 42.34 | 22.77 | 27.39 | - | 13.3 |
| Nifty Pharma TRI | 40.52 | 20.43 | 23.74 | 8.38 | 14.88 |
| Equity: Sectoral-Pharma and Healthcare | 42.48 | 21.9 | 27.72 | 14.27 | 23.87 |
Meeta Shetty
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.
| Key Statistics | Volatility | Sharpe Ratio | Alpha | Beta | Yield to Maturity | Average Maturity |
|---|---|---|---|---|---|---|
| Tata India Pharma & Healthcare Fund-Regular Plan-Growth | 14.23 | 0.87 | 3.14 | 0.9 | - | - |
| Equity: Sectoral-Pharma and Healthcare | - | - | - | - | - | - |